Clinical Trials Browser

Phase 1/2 × Recruiting × 4-(3-fluoropropyl)glutamic acid × Clear all

NCT05501665 2024-10-17

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms